Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Comparative Renoprotective Effect of Febuxostat and Allopurinol in Pre-Dialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis.

Hsu YO, Wu IW, Chang SH, Lee CC, Tsai CY, Lin CY, Lin WT, Huang YT, Wu CY, Kuo G, Hsiao CY, Lin HL, Yang CC, Yen TH, Chen YC, Hung CC, Tian YC, Kuo CF, Yang CW, Anderson GF, Yang HY.

Clin Pharmacol Ther. 2019 Oct 19. doi: 10.1002/cpt.1697. [Epub ahead of print]

PMID:
31628864
2.

Financial Eligibility Criteria and Medication Coverage for Independent Charity Patient Assistance Programs.

Kang SY, Sen A, Bai G, Anderson GF.

JAMA. 2019 Aug 6;322(5):422-429. doi: 10.1001/jama.2019.9943.

PMID:
31386135
3.

Air Ambulances With Sky-High Charges.

Bai G, Chanmugam A, Suslow VY, Anderson GF.

Health Aff (Millwood). 2019 Jul;38(7):1195-1200. doi: 10.1377/hlthaff.2018.05375.

PMID:
31260345
4.

State Efforts to Lower Health Care Prices Paid by Private Insurers.

Sen AP, Willink A, Anderson GF.

JAMA. 2019 Jul 16;322(3):201-202. doi: 10.1001/jama.2019.7028. No abstract available.

PMID:
31194215
5.

Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries.

Kang SY, DiStefano MJ, Socal MP, Anderson GF.

Health Aff (Millwood). 2019 May;38(5):804-811. doi: 10.1377/hlthaff.2018.05207.

PMID:
31059372
6.

The States as Important Laboratories for Federal Prescription Drug Cost-Containment Efforts.

Horvath JC, Anderson GF.

JAMA. 2019 Apr 23;321(16):1561-1562. doi: 10.1001/jama.2019.2189. No abstract available.

PMID:
31012941
7.

Targeting High-Need Beneficiaries in Medicare Advantage: Opportunities to Address Medical and Social Needs.

DuGoff EH, Buckingham W, Kind AJ, Chao S, Anderson GF.

Issue Brief (Commonw Fund). 2019 Feb 1;2019:1-14.

PMID:
30938944
8.

US Spending On Health Care: The Authors Reply.

Anderson GF, Hussey P, Petrosyan V.

Health Aff (Millwood). 2019 Apr;38(4):696. doi: 10.1377/hlthaff.2019.00139. No abstract available.

PMID:
30933589
9.

Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.

Socal MP, Bai G, Anderson GF.

JAMA Intern Med. 2019 Jun 1;179(6):832-833. doi: 10.1001/jamainternmed.2018.7824. No abstract available.

PMID:
30882842
10.

Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context.

Kang SY, Bai G, Karas L, Anderson GF.

Am J Public Health. 2019 Apr;109(4):559-561. doi: 10.2105/AJPH.2018.304946. Epub 2019 Feb 21.

PMID:
30789768
11.

Nurse practitioners and physician assistants in emergency medical services who billed independently, 2012-2016.

Bai G, Kelen GD, Frick KD, Anderson GF.

Am J Emerg Med. 2019 May;37(5):928-932. doi: 10.1016/j.ajem.2019.01.052. Epub 2019 Jan 31.

PMID:
30733103
12.

Consumer Responses to Price Disclosure in Direct-to-Consumer Pharmaceutical Advertising.

Garrett JB, Tayler WB, Bai G, Socal MP, Trujillo AJ, Anderson GF.

JAMA Intern Med. 2019 Mar 1;179(3):435-437. doi: 10.1001/jamainternmed.2018.5976. No abstract available.

PMID:
30667461
13.

It's Still The Prices, Stupid: Why The US Spends So Much On Health Care, And A Tribute To Uwe Reinhardt.

Anderson GF, Hussey P, Petrosyan V.

Health Aff (Millwood). 2019 Jan;38(1):87-95. doi: 10.1377/hlthaff.2018.05144.

PMID:
30615520
14.

Access to Antihypertensive Drugs in China.

Bai G, Bennet C, Wang J, Anderson GF.

Circulation. 2018 Oct 23;138(17):1777-1779. doi: 10.1161/CIRCULATIONAHA.118.033360. No abstract available.

PMID:
30354658
15.

Increasing frequency and share of dermatologic procedures billed by nonphysician clinicians from 2012 to 2016.

Rogers AT, Bai G, Loss MJ, Anderson GF.

J Am Acad Dermatol. 2018 Dec;79(6):1159-1161. doi: 10.1016/j.jaad.2018.07.062. Epub 2018 Oct 15. No abstract available.

PMID:
30336177
16.

Market Power: Price Variation Among Commercial Insurers For Hospital Services.

Bai G, Anderson GF.

Health Aff (Millwood). 2018 Oct;37(10):1615-1622. doi: 10.1377/hlthaff.2018.0567.

PMID:
30273037
17.
18.

Addressing Generic-Drug Market Failures - The Case for Establishing a Nonprofit Manufacturer.

Liljenquist D, Bai G, Anderson GF.

N Engl J Med. 2018 May 17;378(20):1857-1859. doi: 10.1056/NEJMp1800861. No abstract available.

PMID:
29768140
19.

Limited distribution networks stifle competition in the generic and biosimilar drug industries.

Karas L, Shermock KM, Proctor C, Socal M, Anderson GF.

Am J Manag Care. 2018 Apr 1;24(4):e122-e127.

20.

Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.

Bai G, Sen AP, Anderson GF.

Ann Intern Med. 2018 Mar 20;168(6):436-437. doi: 10.7326/M17-2506. Epub 2018 Feb 13. No abstract available. Erratum in: Ann Intern Med. 2018 Jun 19;168(12):904.

PMID:
29435565
21.

The impact of practice guidelines on opioid utilization for injured workers.

Buttorff C, Trujillo AJ, Castillo R, Vecino-Ortiz AI, Anderson GF.

Am J Ind Med. 2017 Dec;60(12):1023-1030. doi: 10.1002/ajim.22779. Epub 2017 Oct 9.

PMID:
28990210
22.

Variation in Emergency Department vs Internal Medicine Excess Charges in the United States.

Xu T, Park A, Bai G, Joo S, Hutfless SM, Mehta A, Anderson GF, Makary MA.

JAMA Intern Med. 2017 Aug 1;177(8):1139-1145. doi: 10.1001/jamainternmed.2017.1598.

23.

Physician Charges and Medicare Payments.

Bai G, Anderson GF.

JAMA. 2017 May 2;317(17):1803. doi: 10.1001/jama.2017.3761. No abstract available. Erratum in: JAMA. 2017 Jun 27;317(24):2554.

PMID:
28464139
24.

Variation in the Ratio of Physician Charges to Medicare Payments by Specialty and Region.

Bai G, Anderson GF.

JAMA. 2017 Jan 17;317(3):315-318. doi: 10.1001/jama.2016.16230. No abstract available.

PMID:
28114540
25.

US Hospitals Are Still Using Chargemaster Markups To Maximize Revenues.

Bai G, Anderson GF.

Health Aff (Millwood). 2016 Sep 1;35(9):1658-64. doi: 10.1377/hlthaff.2016.0093.

PMID:
27605648
26.

Higher Hospital Spending on Occupational Therapy Is Associated With Lower Readmission Rates.

Rogers AT, Bai G, Lavin RA, Anderson GF.

Med Care Res Rev. 2017 Dec;74(6):668-686. doi: 10.1177/1077558716666981. Epub 2016 Sep 2.

PMID:
27589987
27.

Health System Performance for the High-Need Patient: A Look at Access to Care and Patient Care Experiences.

Salzberg CA, Hayes SL, McCarthy D, Radley DC, Abrams MK, Shah T, Anderson GF.

Issue Brief (Commonw Fund). 2016 Aug;27:1-12.

PMID:
27571600
28.

High-Need, High-Cost Patients: Who Are They and How Do They Use Health Care? A Population-Based Comparison of Demographics, Health Care Use, and Expenditures.

Hayes SL, Salzberg CA, McCarthy D, Radley DC, Abrams MK, Shah T, Anderson GF.

Issue Brief (Commonw Fund). 2016 Aug;26:1-14.

PMID:
27571599
29.

Profitable Hospitals: The Authors Reply.

Bai G, Anderson GF.

Health Aff (Millwood). 2016 Aug 1;35(8):1545. doi: 10.1377/hlthaff.2016.0660. No abstract available.

PMID:
27503983
30.

Relationship between continuity of care and adverse outcomes varies by number of chronic conditions among older adults with diabetes.

DuGoff EH, Bandeen-Roche K, Anderson GF.

J Comorb. 2016 Jun 3;6(2):65-72. doi: 10.15256/joc.2016.6.76. eCollection 2016.

31.

A More Detailed Understanding Of Factors Associated With Hospital Profitability.

Bai G, Anderson GF.

Health Aff (Millwood). 2016 May 1;35(5):889-97. doi: 10.1377/hlthaff.2015.1193.

PMID:
27140996
32.

Attributes common to programs that successfully treat high-need, high-cost individuals.

Anderson GF, Ballreich J, Bleich S, Boyd C, DuGoff E, Leff B, Salzburg C, Wolff J.

Am J Manag Care. 2015 Nov 1;21(11):e597-600.

33.

Evaluating Clinical Practice Guidelines Based on Their Association with Return to Work in Administrative Claims Data.

Roberts ET, DuGoff EH, Heins SE, Swedler DI, Castillo RC, Feldman DR, Wegener ST, Canudas-Romo V, Anderson GF.

Health Serv Res. 2016 Jun;51(3):953-80. doi: 10.1111/1475-6773.12360. Epub 2015 Sep 14.

34.

Medicare Payment Reform: Aligning Incentives for Better Care.

Anderson GF, Davis K, Guterman S.

Issue Brief (Commonw Fund). 2015 Jun;20:1-12.

PMID:
26151988
35.

Considering long-term care insurance for middle-income countries: comparing South Korea with Japan and Germany.

Rhee JC, Done N, Anderson GF.

Health Policy. 2015 Oct;119(10):1319-29. doi: 10.1016/j.healthpol.2015.06.001. Epub 2015 Jun 11. Review.

36.

Extreme Markup: The Fifty US Hospitals With The Highest Charge-To-Cost Ratios.

Bai G, Anderson GF.

Health Aff (Millwood). 2015 Jun;34(6):922-8. doi: 10.1377/hlthaff.2014.1414.

PMID:
26056196
37.

Geographic variability of adherence to occupational injury treatment guidelines.

Trujillo AJ, Heins SE, Anderson GF, Castillo RC.

J Occup Environ Med. 2014 Dec;56(12):1308-12. doi: 10.1097/JOM.0000000000000264.

PMID:
25479302
38.

Multiple chronic conditions and life expectancy: a life table analysis.

DuGoff EH, Canudas-Romo V, Buttorff C, Leff B, Anderson GF.

Med Care. 2014 Aug;52(8):688-94. doi: 10.1097/MLR.0000000000000166.

PMID:
25023914
39.

The National Commission on Physician Payment Reform: recalibrating fee-for-service and transitioning to fixed payment models.

Siddiqui M, Joy S, Elwell D, Anderson GF.

J Gen Intern Med. 2014 May;29(5):700-2. doi: 10.1007/s11606-014-2785-1. No abstract available.

40.

Early results of an objective feedback-directed system for the staged traction repair of long-gap esophageal atresia.

Bairdain S, Ricca R, Riehle K, Zurakowski D, Saites CG, Lien C, Anderson GF, Wahoff DC, Linden BC.

J Pediatr Surg. 2013 Oct;48(10):2027-31. doi: 10.1016/j.jpedsurg.2013.05.008.

PMID:
24094952
41.

Medicare beneficiaries most likely to be readmitted.

Berkowitz SA, Anderson GF.

J Hosp Med. 2013 Nov;8(11):639-41. doi: 10.1002/jhm.2074. Epub 2013 Aug 28.

PMID:
24038901
42.

Reevaluating "made in America"--two cost-containment ideas from abroad.

Anderson GF, Willink A, Osborn R.

N Engl J Med. 2013 Jun 13;368(24):2247-9. doi: 10.1056/NEJMp1302140. No abstract available.

PMID:
23758231
43.

Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.

Kanavos P, Ferrario A, Vandoros S, Anderson GF.

Health Aff (Millwood). 2013 Apr;32(4):753-61. doi: 10.1377/hlthaff.2012.0920.

PMID:
23569056
44.

In Japan, all-payer rate setting under tight government control has proved to be an effective approach to containing costs.

Ikegami N, Anderson GF.

Health Aff (Millwood). 2012 May;31(5):1049-56. doi: 10.1377/hlthaff.2011.1037.

PMID:
22566445
45.

Effect of cost-sharing reductions on preventive service use among Medicare fee-for-service beneficiaries.

Goodwin SM, Anderson GF.

Medicare Medicaid Res Rev. 2012 Feb 8;2(1). pii: 002.01.a03. doi: 10.5600/mmrr.002.01.a03. eCollection 2012.

46.

Planned readmissions: a potential solution.

Berkowitz SA, Anderson GF.

Arch Intern Med. 2012 Feb 13;172(3):269-70. doi: 10.1001/archinternmed.2011.606. Epub 2011 Dec 12. No abstract available.

PMID:
22157066
47.

Premature adult mortality from non-communicable diseases (NCD) in three middle-income countries: do NCD programmes matter?

Robles S, Adrion E, Anderson GF.

Health Policy Plan. 2012 Sep;27(6):487-98. doi: 10.1093/heapol/czr073. Epub 2011 Oct 20.

PMID:
22016367
48.

Hospice care and resource utilization in Medicare beneficiaries with heart failure.

Blecker S, Anderson GF, Herbert R, Wang NY, Brancati FL.

Med Care. 2011 Nov;49(11):985-91. doi: 10.1097/MLR.0b013e318235c221.

49.

Type IV laryngotracheoesophageal cleft: report of long-term survivor successfully decannulated.

Owusu JA, Sidman JD, Anderson GF.

Int J Pediatr Otorhinolaryngol. 2011 Sep;75(9):1207-9. doi: 10.1016/j.ijporl.2011.06.010. Epub 2011 Jul 12.

PMID:
21752479
50.

Leadership in creating accountable care organizations.

Anderson GF.

J Gen Intern Med. 2011 Nov;26(11):1368-70. doi: 10.1007/s11606-011-1735-4. Epub 2011 May 10.

Supplemental Content

Loading ...
Support Center